Bobdey S, Sathwara J, Jain A, Balasubramaniam G. Burden of cervical cancer and role of screening in India. Indian J Med Padiatr Oncol. 2016;37:278–85.
Bruni L, Albero G, Serrano B, Mena M, Gomez D, Munoz J, et al. ICO information center on HPV & Cancer (HPV information center). Human papilloma viruses and related diseases in the world. Summary report 27 July 2017. Last accessed 29th April 2019. Available from http://www.hpvcenter.net.
Khong HT, Restifo NP. Natural selection of tumor variants in the generation of “tumor escape” phenotypes. Nat immunol. 2002;3:999–1005.
Article CAS PubMed PubMed Central Google Scholar
Zehbe I, Hohn H, Pilch H, Neukirch C, Freitag K, Maeurer MJ. Differential MHC class II component expression in HPV-possitive cervical cancer cells:implication for immune surveillance. Int J Cancer. 2005;117:807–15.
Article CAS PubMed Google Scholar
Bhatla N, Berek JS, Fredes MC, Denny LA, Grenman S, Karunaratne K, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019;145:129–35.
Bosch FX, De Sanjose S. The epidemiology of human papillomavirus infection and cervican cancer. Dis Markers. 2007;23:213–27.
Article PubMed PubMed Central Google Scholar
Yim EK, Park JS. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat. 2005;37:319–24.
Article PubMed PubMed Central Google Scholar
De Araujo Souza PS, Maciag PC, Ribeiro KB, Petzl-Erler ML, Franco EL, Villa LL. Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer. BMC Cancer. 2008;8:246.
Article PubMed PubMed Central Google Scholar
Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J Womens Health. 2015;7:405–14.
PubMed PubMed Central Google Scholar
Rathika C, Murali V, Dhivakar M, Kamaraj R, Malini RP, Ramgopal S, et al. Susceptible & protective associations of HLA alleles and haplotypes with cervical cancer in South India. Asian Pac J Cancer Prev. 2016;17:2491–7.
Chan DPC, Cheung TH, Tam AOY, Cheung JLK, Yim SF, Lo KWK, et al. Risk association between human leukocyte antigen-A allele and high risk human papilloma virus infection for cervical neoplasia in Chinese women. J Infect Dis. 2005;192:1749–56.
Article CAS PubMed Google Scholar
Gokhale P, Mania-Pramanik J, Sonawani A, Idicula-Thomas S, Kerkar S, Tongaonkar H, et al. Cervical cancer in Indian women reveals contrasting association among common sub-family of HLA class I alleles. Immunogenetics. 2014;66:683–91.
Article CAS PubMed Google Scholar
Zehbe I, Mytilineos J, Wikstrom I, Henriksen R, Edler L, Tommasino M. Association between human papilloma virus 16 E6 variants and human leukocyte antigen class polymorphism in cervical cancer of Swedish women. Hum Immunol. 2003;64:538–42.
Article CAS PubMed Google Scholar
Madeleine MM, Brumback B, Cushing-Haugen KL, Schwartz SM, Daling JR, Smith AG, et al. Human leukocyte antigen class II and cervical cancer risk: a population based study. J Infect Dis. 2002;186:1565–74.
Article CAS PubMed Google Scholar
Yang YC, Chang TY, Lee YJ, Su TH, Dang CW, Wu CC, et al. HLA-DRB1 alleles and cervical squamous cell carcinoma : experimental study & meta analysis. Human Immunol. 2006;67:331–40.
Kamiza AB, Kamiza S, Mathew CG. HLA-DRB1 alleles and cervical cancer: a meta-analysis of 36 case-control studies. Cancer Epidemiol. 2020;1(67): 101748.
Wei LZ, Wang HL, Liu X, Lu YP, Xu F, Yuan JQ, et al. Meta-analysis on the relationship between HLA-DRB1 gene polymorphism and cervical cancer in Chinese population. PLoS ONE. 2014;9: e88439.
Article PubMed PubMed Central Google Scholar
Wu Y, Liu B, Lin W, Xu Y, Li L, Zhang Y, et al. Human leukocyte antigen class II alleles and risk of cervical cancer in China. Human Immunol. 2007;68:192–200.
Gokhale P, Kerkar S, Tongaonkar H, Chaudhari H, Warke H, Salvi V, et al. Variations in immunogenetics, human papillomavirus infection & predisposition to cervical cancer in Indian women. Indian J Med Res. 2014;140:S36-43.
Comments (0)